Interleukin enhancer-binding factor 3 (ILF3) (AA 302-351) Antikörper
Kurzübersicht für Interleukin enhancer-binding factor 3 (ILF3) (AA 302-351) Antikörper (ABIN1453638)
Target
Alle Interleukin enhancer-binding factor 3 (ILF3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 302-351
-
Spezifität
-
NF90 antibody detects endogenous levels of NF90.
-
Aufreinigung
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human NF90.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500~1:1000 ELISA: 1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable at -20°C for at least 1 year.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Andere Bezeichnung
- NF90
-
Hintergrund
-
Synonyms: Interleukin enhancer-binding factor 3, Nuclear factor of activated T-cells 90 kDa, NF-AT-90, Double-stranded RNA-binding protein 76, DRBP76, Translational control protein 80, TCP80, Nuclear factor associated with dsRNA, NFAR, M-phase phosphoprotein 4, MPP
NCBI Gene Symbol: ILF3
-
Molekulargewicht
- 95 kDa
-
Gen-ID
- 3609
-
OMIM
- 603182
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-